Motor protein diseases of the nervous system

References

• Julien J. P. Amyotrophic lateral sclerosis. unfolding the toxicity of the misfolded. Cell 2001; 104: 581–91
   PubMed Web of Science ®Google Scholar
• Murakami T., Nagano I., Hayashi T., Manabe Y., Shoji M., Setoguchi Y., et al. Impaired retrograde axonal transport of adenovirus‐mediated E. coli LacZ gene in the mice carrying mutant SOD1 gene. Neurosci Lett 2001; 308: 149–52
   PubMed Web of Science ®Google Scholar
• LaMonte B. H., Wallace K. E., Holloway B. A., Shelly S. S., Ascano J., Tokito M., et al. Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late‐onset progressive degeneration. Neuron 2002; 34: 715–27
   PubMed Web of Science ®Google Scholar
• Hafezparast M., Klocke R., Ruhrberg C., Marquardt A., Ahmad‐Annuar A., Bowen S., et al. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science 2003; 300: 808–12
   PubMed Web of Science ®Google Scholar
• Hirokawa N., Takemura R. Biochemical and molecular characterization of diseases linked to motor proteins. Trends Biochem Sci 2003; 28: 558–65
   PubMed Web of Science ®Google Scholar
• Schliwa M., Woehlke G. Molecular motors. Nature 2003; 422: 759–65
   PubMed Web of Science ®Google Scholar
• Mandelkow E., Mandelkow E. M. Kinesin motors and disease. Trends Cell Biol 2002; 12: 585–91
   PubMed Web of Science ®Google Scholar
• Seog D. H., Lee D. H., Lee S. K. Molecular motor proteins of the kinesin superfamily proteins (KIFs): structure, cargo and disease. J Korean Med Sci 2004; 19: 1–7
   PubMed Web of Science ®Google Scholar
• Mallik R., Gross S. P. Molecular motors: strategies to get along. Curr Biol 2004; 14: R971–82
   PubMed Web of Science ®Google Scholar
• Heerssen H. M., Pazyra M. F., Segal R. A. Dynein motors transport activated Trks to promote survival of target‐dependent neurons. Nat Neurosci 2004; 7: 596–604
   PubMed Web of Science ®Google Scholar
• Veugelers M., Bressan M., McDermott D. A., Weremowicz S., Morton C. C., Mabry C. C., et al. Mutation of perinatal myosin heavy chain associated with a Carney complex variant. N Engl J Med 2004; 351: 460–9
   PubMed Web of Science ®Google Scholar
• Martinsson T., Oldfors A., Darin N., Berg K., Tajsharghi H., Kyllerman M., et al. Autosomal dominant myopathy: missense mutation (Glu‐706 –> Lys) in the myosin heavy chain IIa gene. Proc Natl Acad Sci. USA 2000; 97: 14614–9
   PubMed Web of Science ®Google Scholar
• Goldstein L. S. Molecular motors: from one motor many tails to one motor many tales. Trends Cell Biol 2001; 11: 477–82
   PubMed Web of Science ®Google Scholar
• Anikster Y., Huizing M., Anderson P. D., Fitzpatrick D. L., Klar A., Gross‐Kieselstein E., et al. Evidence that Griscelli syndrome with neurological involvement is caused by mutations in RAB27A, not MYO5A. Am J Hum Genet 2002; 71: 407–14
   PubMed Web of Science ®Google Scholar
• Menasche G., Fischer A., de Saint B. G. Griscelli syndrome types 1 and 2. Am J Hum Genet 2002; 71: 1237–8
   PubMed Web of Science ®Google Scholar
• Zhao C., Takita J., Tanaka Y., Setou M., Nakagawa T., Takeda S., et al. Charcot‐Marie‐Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell 2001; 105: 587–97
   PubMed Web of Science ®Google Scholar
• Zuchner S., Mersiyanova I. V., Muglia M., Bissar‐Tadmouri N., Rochelle J., Dadali E. L., et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot‐Marie‐Tooth neuropathy type 2A. Nat Genet 2004; 36: 449–51
   PubMed Web of Science ®Google Scholar
• Yamada K., Chan W. M., Andrews C., Bosley T. M., Sener E. C., Zwaan J. T., et al. Identification of KIF21A mutations as a rare cause of congenital fibrosis of the extraocular muscles type 3 (CFEOM3). Invest Ophthalmol Vis Sci 2004; 45: 2218–23
   PubMed Web of Science ®Google Scholar
• Reid E., Kloos M., Ashley‐Koch A., Hughes L., Bevan S., Svenson I. K., et al. A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10). Am J Hum Genet 2002; 71: 1189–94
   PubMed Web of Science ®Google Scholar
• Fichera M., Lo G. M., Falco M., Sturnio M., Amata S., Calabrese O., et al. Evidence of kinesin heavy chain (KIF5A) involvement in pure hereditary spastic paraplegia. Neurology 2004; 63: 1108–10
   PubMed Web of Science ®Google Scholar
• Xiao G. H., Chernoff J., Testa J. R. NF2: the wizardry of merlin. Genes Chromosomes Cancer 2003; 38: 389–99
   PubMed Web of Science ®Google Scholar
• McDermott C. J., Grierson A. J., Wood J. D., Bingley M., Wharton S. B., Bushby K. M., et al. Hereditary spastic paraparesis: disrupted intracellular transport associated with spastin mutation. Ann Neurol 2003; 54: 748–59
   PubMed Web of Science ®Google Scholar
• Vallee R. B., Faulkner N. E., Tai C. Y. The role of cytoplasmic dynein in the human brain developmental disease lissencephaly. Biochim Biophys Acta 2000; 1496: 89–98
   PubMed Web of Science ®Google Scholar
• Tanaka T., Serneo F. F., Higgins C., Gambello M. J., Wynshaw‐Boris A., Gleeson J. G. Lis1 and double cortin function with dynein to mediate coupling of the nucleus to the centrosome in neuronal migration. J Cell Biol 2004; 165: 709–21
   PubMed Web of Science ®Google Scholar
• Hafezparast M., Ahmad‐Annuar A., Hummerich H., Shah P., Ford M., Baker C., et al. Paradigms for the identification of new genes in motor neuron degeneration. Amyotroph Lateral Scler Other Motor Neuron Disord 2003; 4: 249–57
   PubMed Web of Science ®Google Scholar
• Ahmad‐Annuar A., Shah P., Hafezparast M., Hummerich H., Witherden A. S., Morrison K. E., et al. No association with common Caucasian genotypes in exons 8, 13 and 14 of the human cytoplasmic dynein heavy chain gene (DNCHC1) and familial motor neuron disorders. Amyotroph Lateral Scler Other Motor Neuron Disord 2003; 4: 150–7
   PubMed Web of Science ®Google Scholar
• Munch C., Sedlmeier R., Meyer T., Homberg V., Sperfeld A. D., Kurt A., et al. Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS. Neurology 2004; 63: 724–6
   PubMed Web of Science ®Google Scholar
• Puls I., Jonnakuty C., LaMonte B. H., Holzbaur E. L., Tokito M., Mann E., et al. Mutant dynactin in motor neuron disease. Nat Genet 2003; 33: 455–6
   PubMed Web of Science ®Google Scholar
• Hanz S., Perlson E., Willis D., Zheng J. Q., Massarwa R., Huerta J. J., et al. Axoplasmic importins enable retrograde injury signalling in lesioned nerve. Neuron 2003; 40: 1095–104
   PubMed Web of Science ®Google Scholar
• De Vos K., Severin F., van Herreweghe F., van Compernolle K., Goossens V., Hymann A., et al. Tumour necrosis factor induces hyperphosphorylation of kinesin light chain and inhibits kinesin‐mediated transport of mitochondria. J Cell Biol 2000; 149: 1207–14
   PubMed Web of Science ®Google Scholar
• Morfini G., Szebenyi G., Brown H., Pant H. C., Pigino G., DeBoer S., et al. A novel CDK5‐dependent pathway for regulating GSK3 activity and kinesin‐driven motility in neurons. EMBO J 2004; 23: 2235–45
   PubMed Web of Science ®Google Scholar